Issue 4 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

29

No.

4

April 28, 2006Apr 28, 2006

Free

DOWNLOAD THE PDF

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

Benefit Of Chemotherapy Depends ER Status

WHI Update: No Increased Risk Of Cancer With Estrogen-Alone

Panitumumab Improves PFS In Metastatic Colon Cancer

NCI-Approved Trials Listed

Recent Issues

Volume 52 | Issue 41 - November 06, 2026

Volume 52 | Issue 40 - October 30, 2026

Volume 52 | Issue 39 - October 23, 2026

Volume 52 | Issue 38 - October 16, 2026

Volume 52 | Issue 37 - October 09, 2026

Volume 52 | Issue 36 - October 02, 2026